DK1330656T3 - Midler til detektion af patologiske transformationer af proteinet APP og anvendelser heraf - Google Patents

Midler til detektion af patologiske transformationer af proteinet APP og anvendelser heraf

Info

Publication number
DK1330656T3
DK1330656T3 DK01992896T DK01992896T DK1330656T3 DK 1330656 T3 DK1330656 T3 DK 1330656T3 DK 01992896 T DK01992896 T DK 01992896T DK 01992896 T DK01992896 T DK 01992896T DK 1330656 T3 DK1330656 T3 DK 1330656T3
Authority
DK
Denmark
Prior art keywords
app
applications
app protein
detecting pathological
detecting
Prior art date
Application number
DK01992896T
Other languages
Danish (da)
English (en)
Inventor
Andre Delacourte
Nicolas Sergeant
Original Assignee
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of DK1330656T3 publication Critical patent/DK1330656T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK01992896T 2000-11-03 2001-11-05 Midler til detektion af patologiske transformationer af proteinet APP og anvendelser heraf DK1330656T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0014143A FR2816411B1 (fr) 2000-11-03 2000-11-03 Moyens de detection de la transformation pathologique de la proteine app et leurs applications
PCT/FR2001/003410 WO2002037118A1 (fr) 2000-11-03 2001-11-05 Moyens de detection de la transformation pathologique de la proteine app et leurs applications

Publications (1)

Publication Number Publication Date
DK1330656T3 true DK1330656T3 (da) 2008-08-11

Family

ID=8856055

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01992896T DK1330656T3 (da) 2000-11-03 2001-11-05 Midler til detektion af patologiske transformationer af proteinet APP og anvendelser heraf

Country Status (13)

Country Link
US (1) US7723117B2 (de)
EP (1) EP1330656B1 (de)
JP (1) JP4294953B2 (de)
AT (1) ATE392620T1 (de)
AU (2) AU2374302A (de)
CA (1) CA2427604A1 (de)
CY (1) CY1108182T1 (de)
DE (1) DE60133661T2 (de)
DK (1) DK1330656T3 (de)
ES (1) ES2305126T3 (de)
FR (1) FR2816411B1 (de)
PT (1) PT1330656E (de)
WO (1) WO2002037118A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2211183E (pt) * 2003-11-19 2013-05-31 Satoris Inc Método para diagnosticar e monitorizar a doença de alzheimer
US20060094064A1 (en) * 2003-11-19 2006-05-04 Sandip Ray Methods and compositions for diagnosis, stratification, and monitoring of alzheimer's disease and other neurological disorders in body fluids
ATE524181T1 (de) 2004-11-10 2011-09-15 Inst Nat Sante Rech Med Verwendung von 1,4-bis (3-aminoalkyl) piperazin- derivaten bei der behandlung von neurodegenerativen erkrankungen
WO2008150845A1 (en) * 2007-05-31 2008-12-11 Vanderbilt University Screening for wnt pathway modulators and pyrvinium for the treatment of cance
DE202007015863U1 (de) * 2007-11-12 2009-03-26 Melitta Haushaltsprodukte Gmbh & Co. Kommanditgesellschaft Filterpapiereinsatz
EP3358354B1 (de) 2008-01-18 2020-07-15 President and Fellows of Harvard College Verfahren zur detektion von anzeichen einer krankheit oder eines leidens in körperflüssigkeiten
WO2011073322A1 (en) 2009-12-16 2011-06-23 Institut National De La Sante Et De La Recherche Medicale (Inserm) 7-chloro-quinolin-4-amine compounds and uses thereof for the prevention or treatment of diseases involving formation of amyloid plaques and/or where a dysfunction of the app metabolism occurs
CA2806293A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
US20130203624A1 (en) 2010-07-23 2013-08-08 President And Fellows Of Harvard College Methods of Detecting Prenatal or Pregnancy-Related Diseases or Conditions
MX382244B (es) 2010-07-23 2025-03-13 Harvard College Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales
SG10201505724SA (en) 2010-07-23 2015-09-29 Harvard College Methods of detecting diseases or conditions using phagocytic cells
US20130096552A1 (en) * 2011-10-14 2013-04-18 Christopher L. Brace Hydrodissection Material with Reduced Migration
SG11201408383SA (en) 2012-06-15 2015-01-29 Harry Stylli Methods of detecting diseases or conditions using circulating diseased cells
EP4202441A3 (de) 2013-03-09 2023-07-26 Immunis.AI, Inc. Genexpressionsprofil in makrophagen zur diagnose von krebs
CA2907765C (en) 2013-03-21 2021-07-06 Eupraxia Pharmaceuticals USA LLC Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith
TW201720427A (zh) 2015-10-27 2017-06-16 優普順藥物股份有限公司 局部麻醉劑之持續釋放調配物
US11397188B2 (en) * 2017-03-30 2022-07-26 Board Of Regents, The University Of Texas System Method of detecting an APP Alzheimer's disease marker peptide in patients with Alzheimer's disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234814A (en) * 1989-06-01 1993-08-10 Du Pont Merck Pharmaceutical Company Diagnostic assay for alzheimer's disease
WO1992000521A1 (en) * 1990-06-29 1992-01-09 Case Western Reserve University Diagnostic and prognostic methods based on soluble derivatives of the beta amyloid protein precursor
CA2086165A1 (en) * 1992-04-09 1993-10-10 Paul P. Tamburini Diagnostic assay for alzheimer's disease based on the proteolysis of alzheimer's precursor protein
US5441870A (en) * 1992-04-15 1995-08-15 Athena Neurosciences, Inc. Methods for monitoring cellular processing of β-amyloid precursor protein
AU5135393A (en) * 1992-09-21 1994-04-12 United States Of America, As Represented By The Secretary, Department Of Health And Human Services A method of screening compounds and methods for treating alzheimer's disease
US6114133A (en) * 1994-11-14 2000-09-05 Elan Pharmaceuticals, Inc. Methods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-β peptide (x-≧41)

Also Published As

Publication number Publication date
WO2002037118A1 (fr) 2002-05-10
CY1108182T1 (el) 2014-02-12
EP1330656B1 (de) 2008-04-16
FR2816411A1 (fr) 2002-05-10
US20070026527A1 (en) 2007-02-01
US7723117B2 (en) 2010-05-25
EP1330656A1 (de) 2003-07-30
DE60133661D1 (de) 2008-05-29
CA2427604A1 (fr) 2002-05-10
DE60133661T2 (de) 2009-05-28
ATE392620T1 (de) 2008-05-15
AU2374302A (en) 2002-05-15
PT1330656E (pt) 2008-07-24
ES2305126T3 (es) 2008-11-01
AU2002223743B2 (en) 2007-01-11
JP4294953B2 (ja) 2009-07-15
JP2004522940A (ja) 2004-07-29
FR2816411B1 (fr) 2003-07-04

Similar Documents

Publication Publication Date Title
AU2374302A (en) Means for detecting pathological transformation of the app protein and their uses
DK1945622T3 (da) Isotopisk-mærkede benzofuranforbindelser som billeddannelsesmidler til amyloidogene proteiner
DK0971033T3 (da) Test og model til Alzheimers sygdom
DK1155325T3 (da) Fremgangsmåde til diagnosticering af og skelnen mellem typer af slagtilfælde
NO20075671L (no) Neurodegenerative markorer for psykiatriske tilstander
DK1625403T3 (da) Fremgasngsmåde til forudsigelsen, diagnosen og differentialdiagnosen af Alzheimers sygdom
DK1594833T3 (da) 1-phenylalkancarboxylsyrederivater til behandling af neurodegenerative sygdomme
FR2810739B1 (fr) Immunodosage electrochimiques a l'aide de marqueurs metalliques colloidaux
EP2251695A3 (de) Mit endometrialer krankheit assoziierte marker
DK2380583T3 (da) Små peptider til behandling af Alzheimers sygdom og andre beta-amyloidprotein-fibrillogeneseforstyrrelser
EP0660700A4 (de) Verfahren zur dauerverformung von keratinmaterial.
HUP0301812A2 (hu) Átvizsgálási (screening) eljárás
BR0014150A (pt) Diagnósticos e terapêuticos para osteoporose
EP1543331A4 (de) Verfahren zur diagnose von morbus alzheimer
DE69535901D1 (de) Proteinkinase npk-110
DE69109542D1 (de) Tragbare Vorrichtung zur Anzeige von Positionsinformation zwecks Bestimmung des Standortes eines Objekts.
ATE522230T1 (de) Biphenyle als bilderzeugungsmittel bei der alzheimerschen krankheit
DE69913325D1 (de) Nephrin gen und protein
DE60234250D1 (de) Vorrichtung zur Zell- bzw. Gewebezüchtung
DE10343826A1 (de) Knochenfester Lokator und optisches Navigaionssystem
AU2001254634A1 (en) Use of neuregulin-beta as an indicator and/or target
FR2852096B1 (fr) Instrument indicateur de direction permettant d'indiquer l'heure et la direction de la mecque.
AU2003235113A8 (en) Method of measuring neprilysin activity
ITRM930038A0 (it) Corredo per analisi microbiologiche mediante coltura.
EP1692155A4 (de) System und verfahren zur auswahl von nukleinsäuren und polypeptiden